Review of the comparative susceptibility of microbial species to photoinactivation using 380-480 nm violet-blue light by Tomb, Rachael M. et al.
Tomb, Rachael M. and White, Tracy A. and Coia, John E. and Anderson, 
John G. and MacGregor, Scott J. and Maclean, Michelle (2018) Review of 
the comparative susceptibility of microbial species to photoinactivation 
using 380-480 nm violet-blue light. Photochemistry and Photobiology, 94 
(3). pp. 445-458. ISSN 0031-8655 , http://dx.doi.org/10.1111/php.12883
This version is available at https://strathprints.strath.ac.uk/62596/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any correspondence concerning this service should be sent to the Strathprints administrator: 
strathprints@strath.ac.uk
The Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research 
outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the 
management and persistent access to Strathclyde's intellectual output.
Photochemistry and Photobiology, 20**, **: *–*
Invited Review
Review of the Comparative Susceptibility of Microbial Species to
Photoinactivation Using 380–480 nm Violet-Blue Light
Rachael M. Tomb1* , Tracy A. White1, John E. Coia2, John G. Anderson1, Scott J. MacGregor1 and
Michelle Maclean1,3
1The Robertson Trust Laboratory for Electronic Sterilisation Technologies (ROLEST), Department of Electronic & Electrical
Engineering, University of Strathclyde, Glasgow, UK
2Department of Clinical Microbiology, Glasgow Royal Inﬁrmary, Glasgow, UK
3Department of Biomedical Engineering, University of Strathclyde, Glasgow, UK
Received 19 October 2017, accepted 8 December 2017, DOI: 10.1111/php.12883
ABSTRACT
Antimicrobial violet-blue light is an emerging technology
designed for enhanced clinical decontamination and treat-
ment applications, due to its safety, efﬁcacy and ease of use.
This systematized review was designed to compile the current
knowledge on the antimicrobial efﬁcacy of 380–480 nm light
on a range of health care and food-related pathogens including
vegetative bacteria, bacterial endospores, fungi and viruses.
Data were compiled from 79 studies, with the majority focuss-
ing on wavelengths in the region of 405 nm. Analysis indicated
that Gram-positive and Gram-negative vegetative bacteria are
the most susceptible organisms, while bacterial endospores,
viruses and bacteriophage are the least. Evaluation of the dose
required for a 1 log10 reduction of key bacteria compared to
population, irradiance and wavelength indicated that micro-
bial titer and light intensity had little effect on the dose of
405 nm light required; however, linear analysis indicated
organisms exposed to longer wavelengths of violet-blue light
may require greater doses for inactivation. Additional research
is required to ensure this technology can be used effectively,
including: investigating inactivation of multidrug-resistant
organisms, fungi, viruses and protozoa; further knowledge
about the photodynamic inactivation mechanism of action; the
potential for microbial resistance; and the establishment of a
standardized exposure methodology.
INTRODUCTION
Traditionally, visible light inactivation of microorganisms has
been associated with photodynamic inactivation (PDI). This inac-
tivation method utilizes exogenous photosensitizers such as
methylene blue, rose bengal or cationic porphyrins, which in the
presence of oxygen become excited when exposed to different
wavelengths of light, including violet-blue (380–500 nm) and
red (625–740 nm) (1–5). These excited photosensitizers produce
reactive oxygen species (ROS), such as singlet oxygen and
hydroxyl radicals, which can damage many structures within
microorganisms, including proteins, lipids and nucleic acids
(2,6–8). This leads to cellular damage and inactivation of bacte-
ria, yeasts, fungi, viruses and parasites (9).
Research carried out over the last decade has indicated that
exogenous porphyrins are not always required for visible light
inactivation of microorganisms and that violet-blue light wave-
lengths possess the potential for antimicrobial capabilities. Early
studies by Hamblin et al. (10) indicated Helicobacter pylori
could be inactivated by at least 99% following a dose of
20 J cm2 of violet-blue 405 nm light. The authors believed this
was due to the presence of high levels of the intracellular por-
phyrins coproporphyrin and protoporphyrin IX, which produce
ROS upon illumination. These ﬁndings were further supported
by Guffey and Wilborn (11), who demonstrated a successful
88% and 91% reduction of Staphylococcus aureus and Pseu-
domonas aeruginosa following exposure to 405 nm light.
Shortly after this, studies by Maclean et al. (12,13) demonstrated
the oxygen enhancement of the visible light inactivation of
S. aureus—supporting the theory that inactivation was via a pho-
todynamic process—and that within the violet-blue light region,
antimicrobial activity peaked with exposure to wavelengths of
around 405 nm (10 nm).
Subsequently, many studies have investigated the antimicrobial
efﬁcacy of 405 nm light and also the broader violet-blue wave-
lengths. For example, Haughton et al. (2012) inactivated Campy-
lobacter jejuni using 395 nm light, while Bumah et al. (14,15)
demonstrated the antimicrobial efﬁcacy of 470 nm light against
Salmonella enterica and S. aureus. Additionally, a small number
of bacterial endospores, fungi and yeasts have been inactivated
using violet-blue light (16–23). To date, little is known about
viral susceptibility; however, there is now published evidence
demonstrating 405 nm light inactivation of a viral surrogate, bac-
teriophage ɸC31, and a mammalian virus, feline calicivirus,
without the requirement of additional photosensitizers (24,25).
To allow greater understanding of antimicrobial scope and
efﬁcacy of violet-blue light, this systematized review was
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designed to compare the inactivation efﬁcacy of 380–480 nm
light on a range of microorganisms including bacteria, fungi and
viruses, using data from peer-reviewed research studies. The
analysis of the antimicrobial efﬁcacy of violet-blue light includes
the following parameters: the effect of population density, the
effect of irradiance and comparison of the average doses required
for 1 log10 reduction using light between 380 and 480 nm. Per-
forming this analysis will help to gain advanced knowledge and
draw conclusions about violet-blue light inactivation of different
microbial species, the most effective wavelengths, and addition-
ally indicate further areas of research which require to be investi-
gated.
METHODOLOGY
Database search and study inclusion
Two databases, PubMed and Science Direct, were searched for
articles from the past thirty years (May 1987–May 2017).
Search terms used key words associated with violet-blue light
technology (i.e. individual wavelengths between 380 and
480 nm, blue light, visible light) and decontamination (inactiva-
tion, kill, antimicrobial, decontamination, disinfection, antibacte-
rial, antiviral, antifungal, photoinactivation, photosensitizers).
The ﬁrst 20 pages of each web search were screened (equiva-
lent to 400 papers), or all pages if the search generated less
than 20 pages. Additional references added to the screening list
included research papers (found in the references section of
review papers or in the author’s personal collection) as well as
2 PhD theses by Bache (26) and Tomb (27), as these contained
inactivation data not currently published elsewhere. Once com-
bined and duplicates excluded, the search yielded 9058 articles
(Fig. 1). The titles and abstracts were then screened to identify
relevant peer-reviewed papers and those which were not rele-
vant to this review were excluded, for example, studies on PDI,
studies inducing endogenous porphyrin production and those
which used wavelengths of light outwith 380–480 nm. Follow-
ing the initial screening process, 153 articles underwent a full-
literature review. An additional 74 papers were subsequently
removed, including reviews on violet-blue light or research
studies which performed experiments outwith the scope of this
review, for example, violet-blue light inactivation of microor-
ganisms exposed on food, bacterial bioﬁlms and pathogens on
environmental surfaces.
Data extraction and analysis
The ﬁnal 79 research articles reviewed (7,10–87) contained inac-
tivation data on clinically relevant and food-associated microor-
ganisms exposed to violet-blue light between 380 and 480 nm.
Data from each article were extracted, summarized and tabulated
(see Supporting Information). This included information on
microorganism (categorized by species and strain number), wave-
length of light, irradiance of light source, applied dose and popu-
lation exposed.
Subsequent analysis of inactivation kinetics was based upon
that of Hessling et al. (88). Log10 reduction values were
extracted from text and tables, or if unavailable, extracted from
ﬁgures. The highest dose reported, for the greatest signiﬁcant
inactivation of each exposed population, was recorded; however,
if prominent tailing of results occurred, the previous dose was
used in the analysis. Recording data in this way allowed the cal-
culation of the average dose required for 1 log10 reduction (total
dose of light/total log10 inactivation) and therefore allowed com-
parison between studies investigating different: organisms, irradi-
ances of light, wavelengths of violet-blue light and exposed
populations.
The data extracted include inactivation at low (≤10°C) or high
(≥37°C) temperatures. However, as violet-blue light inactivation
of bacteria has been shown to be enhanced in low or elevated
temperatures (43), the results of these studies were excluded
from ﬁgures. Similarly, information on inactivation in anaerobic
conditions is included in the data set, but excluded from any
additional ﬁgures on the dose analysis.
Statistical analysis of data sets was performed using Minitab
statistical software, version 17 (Minitab Ltd, Coventry, UK).
One-way ANOVA with post hoc Fisher’s test was used to ana-
lyze dose requirements between microbial groups, with signiﬁ-
cant differences when P < 0.05. Linear regression analysis was
used to investigate signiﬁcant relationships between x & y val-
ues, with signiﬁcant relationships demonstrated when P < 0.05.
RESULTS
Data were retrieved from 79 sources providing information on
the inactivation kinetics of a range of microorganisms using vio-
let-blue light between 380 and 480 nm. There were >370 indi-
vidual entries accumulated, including 57 bacterial strains, 8
yeasts and fungi, 1 bacteriophage and 2 mammalian viruses (see
Supporting Information).
As an overall comparison of the data gathered, Fig. 2 repre-
sents the dose required for 1 log10 inactivation of the different
microbial species, at the various wavelengths investigated. It
should be noted that fungal inactivation data were split by mor-
phological group: hyphae, conidia, germinating conidia and
yeasts, to demonstrate the varying susceptibility in later analysis.
As can be seen in Fig. 2, the majority of light inactivation stud-
ies have been carried out using violet-blue light peaking at
405 nm (n = 51). Additionally, there is interest in inactivation at
longer wavelengths of blue light including 415 nm (n = 8),
450 nm (n = 5) and 470 nm (n = 8). The majority of Gram-posi-
tive and Gram-negative vegetative cells required doses
<200 J cm2 (246 out of 280 studies). However, Gram-positive
endospores, fungal spores, yeast, viruses and bacteriophage
generally required >400 J cm2 for a 1 log10 reduction.
Additionally, the data were collated to determine the general
susceptibility across the different microbial groups. The average
dose for a 1 log10 reduction using light between 380 and
480 nm was calculated for each individual microbial species
(where possible), with results demonstrated in Fig. 3. As can be
seen in Fig. 3, Gram-negative and Gram-positive vegetative bac-
teria are most susceptible with mean doses of in the region of
100 J cm2 required for 1 log10 reduction, whereas viruses and
bacteriophage were least susceptible with up to 1 kJ cm2
required for a 1 log10 reduction. One-way ANOVA with Fisher’s
post hoc test indicated no signiﬁcant difference between dose
requirements for Gram-positive and Gram-negative vegetative
bacteria and yeasts, while these groups were all signiﬁcantly dif-
ferent to bacterial spores, germinating fungal conidia, viruses and
bacteriophage (P < 0.05).
Similar to Hessling et al. (88), it was possible to perform fur-
ther analysis on the data collected with regard to individual
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Gram-positive and Gram-negative bacteria. The most common
Gram-positive organisms that have been investigated are S. au-
reus (n = 30 studies) and Listeria monocytogenes (n = 8 stud-
ies), and the most common Gram-negative bacteria are
Escherichia coli (n = 25 studies) and P. aeruginosa (n = 14
studies). Using these organisms, comparisons were made
between the dose for 1 log10 reduction using 405 nm light and
the starting population (Fig. 4) or applied irradiance (Fig. 5).
Additionally, the dose for 1 log10 reduction of these organisms
was compared between the differing wavelengths (380–480 nm)
of violet-blue light (Fig. 6).
Upon comparison of the starting population with the dose of
405 nm light required for 1 log10 reduction, the linear ﬁt indi-
cates that with increasing populations of S. aureus, E. coli and
L. monocytogenes higher doses of 405 nm light are required,
whereas in the case of P. aeruginosa, it appears that as the
concentration increases, the dose required decreases (Fig. 4).
However, as the Pearson’s r values for the linear correlation
analysis of all the bacteria investigated are between 0.12 and
0.23, and P values are >0.05, these indicate that there is no
signiﬁcant linear relationship, so no true conclusions can be
drawn.
Upon comparison of the irradiance of 405 nm light used, the
linear ﬁt suggests that for S. aureus and P. aeruginosa, there is
little change in dose required for 1 log10 reduction as irradiance
increases (Fig. 5). However, regarding inactivation of E. coli and
L. monocytogenes, this is not the case, with higher irradiances
resulting in the dose increasing for E. coli inactivation, and the
dose decreasing for L. monocytogenes inactivation. However,
analysis of the Pearson’s r values for the linear correlation indi-
cates no linear relationship for E. coli (0.22) and a weak nega-
tive linear relationship (0.3) for L. monocytogenes; therefore,
no true signiﬁcant conclusions can be drawn.
Additionally, the wavelength of violet-blue light used was
compared with the dose for 1 log10 reduction of the four vegeta-
tive bacterial species. As can be seen in Fig. 6, there is very lit-
tle difference in dose required when exposing S. aureus and
P. aeruginosa to different wavelengths of violet-blue light; how-
ever, this is not the case with L. monocytogenes and E. coli. As
the wavelength increases, the dose for 1 log10 reduction
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Figure 1. Flow chart of the study selection process during the systematized review.
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increases, with Pearson’s r values of 0.39 and 0.73, indicating
that there is a moderately strong positive correlation between the
wavelength used and dose required for these organisms. This is
additionally supported by P values of 0.020 and 0.001 for E. coli
and L. monocytogenes, respectively, indicating that there is a
statically signiﬁcant relationship between wavelength and dose
for both organisms.
A ﬁnal analysis was conducted to establish the comparative
inactivation efﬁcacy of shorter wavelengths of violet-blue light
(~405 nm) to longer wavelengths (450–470 nm) and is demon-
strated in Fig. 7. Data were collected from several studies which
investigated the inactivation of bacteria, using different wave-
lengths of violet-blue light, held under similar exposure condi-
tions in each study (11,12,14,31,36,39,45,52,58). Figure 7a
demonstrates data for Gram-positive isolates, with the dose
required for a 1 log10 reduction increasing for all organisms
when wavelength is increased from 405–415 nm to 450–
470 nm. The exception being the dose required for inactivation
of Streptococcus inniae which decreased from 90.3 to
70.6 J cm2 when wavelength was increased from 405 to
465 nm (31). The data for inactivation of Gram-negative isolates
(Fig. 7b) also demonstrate that for all organisms analyzed, higher
doses were required for inactivation when longer wavelengths of
violet-blue light were utilized. Lower does were required for 1
log10 reduction of Enterococcus facecalis and E. coli when
exposed to 385 nm violet-blue light compared to 405 nm (39);
however, this is to be expected as 385 nm lies within the UVA
spectrum (320–400 nm).
DISCUSSION
To investigate the antimicrobial scope and efﬁcacy of violet-blue
light, a systematized review was carried out to compare the dose
required for 1 log10 reduction of a range of microorganisms. This
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Figure 2. Comparison of the dose for a 1 log10 reduction of a range of microorganisms, when exposed to differing wavelengths of violet-blue light.
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Figure 3. Box plot analysis of the average dose for 1 log10 reduction between different microbial groups. Please note that in the case of the Gram-posi-
tive and Gram-negative bacteria, the aerobic, anaerobic, facultative aerobic, facultative anaerobic and microaerophilic organisms have been grouped
together. Crosses “9” indicate the mean dose for a 1 log10 reduction.
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allowed comparison of the inactivation data generated between
research groups, indicated how the efﬁcacy of violet-blue com-
pares between organisms and conﬁrmed areas of antimicrobial
violet-blue light research which require further investigation.
The systematized review indicated many differences in the
light sources and experimental arrangements used between
research groups. Major differences in the experimental arrange-
ment included how microorganisms were exposed, with some
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Figure 4. Comparisons of the dose for 1 log10 reduction of Gram-positive and Gram-negative bacteria, using 405 nm light, when there are differing
population densities. P values >0.05 indicate no statistically signiﬁcant relationship between population density and dose requirement values, using linear
regression analysis.
E. coli
L. monocytogenes
P. aeruginosa
S. aureus
Linear fit E. coli, Pearson's r = 0.21741, P = 0.402
Linear fit L. monocytogenes, Pearson's r = -0.29011, P = 0.416
Linear fit P. aeruginosa, Pearson's r = -0.04121, P = 0.856
Linear fit S. aureus, Pearson's r = -0.06778, P = 0.727
0 25 50 75 100 125 150 175
0
200
400
600
800
1000
1200
D
o
se
fo
r
1
L
o
g
1
0
R
ed
u
ct
io
n
(J
cm
-2
)
Irradiance (mW cm
-2
)
Figure 5. Comparisons of the dose for 1 log10 reduction of Gram-positive and Gram-negative bacteria, when exposed to differing irradiances of
405 nm light. P values >0.05 indicate no statistically signiﬁcant relationship between irradiance and dose requirement values, using linear regression
analysis.
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studies exposing organisms on agar plates, while others exposed
organisms in suspension (1 lL-40 mL). Light sources varied
with different groups using single LEDs and arrays (1–144
LEDs) to broadband sources with ﬁlters, which emitted violet-
blue light at irradiances ranging from 1.2 to 520 mW cm2.
Exposure times also ranged from 20 s to 48 h, with exposed
population densities of between 101 and 109 CFU. Furthermore,
as complete data sets were not always available, and at times the
experimental arrangement was unclear, it was not possible to use
mathematical models of inactivation kinetics such as the Kamau,
Gompertz, Weibull or Hom models (33). Therefore, dose for 1
log10 reduction, as demonstrated by Hessling et al. (88), was the
most appropriate means of comparison.
Despite these methodological variations, several comparisons
could be made using the data gathered in the systematized
review, including comparing the overall susceptibility of
microorganisms to violet-blue light with dose for 1 log10 reduc-
tion. The data in Fig. 2 compare the dose of 380–480 nm light
required between different organisms, with further analysis of
these data provided in Fig. 3 comparing the average dose
requirements between microbial groups. As can be seen in
Fig. 3, Gram-positive and Gram-negative vegetative bacteria
appear to require fairly similar doses of violet-blue light for 1
log10 inactivation, with mean doses of 126.5 J cm
2
(6–748 J cm2) and 105.6 J cm2 (0.3–444 J cm2) required,
respectively. A two-sample t-test also revealed the dose require-
ments for these groups were not signiﬁcantly different
(P = 0.655). This differs from previously published data, which
indicated that Gram-positive bacteria are more sensitive to violet-
blue light inactivation then Gram-negative bacteria (7,38,50).
However, the results in this review do mirror those of Hessling
et al. (88) who also demonstrated no evidence of increased
susceptibility of Gram-positive bacteria when compared to
Gram-negative bacteria. It is worth noting, however, that the data
for bacterial inactivation include aerobic, anaerobic, facultative
aerobic, facultative anaerobic and microaerophilic species. It is
possible that grouping these organisms has skewed the data, and
this may be particularly pertinent with regard to Gram-negative
organisms, as studies have demonstrated high sensitivity of
microaerophilic (Campylobacter, Helicobacter) and anaerobic
(Fusobacterium) organisms. For example, C. jejuni required a
dose of 18 J cm2 for >5 log10 reduction (37), H. pylori
required 10–20 J cm2 for up to 6 log10 reduction (10), and
Fusobacterium nucleatum required an average dose of
17.8 J cm2 for a 1 log10 reduction (56), whereas facultatively
anaerobic organisms such as Escherichia and Salmonella gener-
ally require greater doses of violet-blue for inactivation, with
studies demonstrating as much as 2214 J cm2 required for a 5
log10 reduction of E. coli (20) and 739.6 J cm
2 for a 1.4 log10
reduction of S. enterica serovar enteritidis (52). Therefore, future
reviews could involve in-depth analysis of these organisms to
discover whether sensitivity to violet-blue light is linked with
microbial oxygen requirements.
Results in Fig. 3 additionally indicate that yeast cells have
similar dose requirements to vegetative bacteria (P = 0.874,
using one-way ANOVA), with the average dose of 131.6 J cm2
required for 1 log10 reduction. Mycobacteria, fungal conidia, fun-
gal hyphae, germinating/germinated fungal conidia and bacterial
endospores all required increasingly greater doses of violet-blue
light compared to vegetative bacteria. The mean average doses
being 354 J cm2 for mycobacteria, 437 J cm2 for fungal coni-
dia, 480 J cm2 for fungal hyphae, 523 J cm2 for germinating/
germinated fungal conidia and 641 J cm2 for bacterial endo-
spores. Viruses appeared to be least susceptible with the highest
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Linear fit L. monocytogenes, Pearson's r = 0.73314, P = 0.001
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Figure 6. Comparisons of the dose for 1 log10 reduction of Gram-positive and Gram-negative bacteria, when exposed to differing wavelengths of vio-
let-blue light. P values <0.05 indicate a statistically signiﬁcant relationship between wavelength of light and dose requirements, using linear regression
analysis.
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mean doses of 718 and 1020 J cm2 required for 1 log10 reduc-
tion for viruses and bacteriophage, respectively.
Comparisons were also made between several species of bac-
teria (two Gram positive and two Gram negative) due to the
large number of results collected during the systematized review.
The effect of population density and irradiance of 405 nm light
on the average dose for 1 log10 reduction was compared between
E. coli, L. monocytogenes, P. aeruginosa and S. aureus. With
regard to the population density used, the linear correlation
trends indicated a slight increase in the dose requirements upon
increasing population, with the exception of P. aeruginosa
(Fig. 4). This is reﬂected in a study by Maclean et al. (7) who
demonstrated that a dose of 36 J cm2 was required for a 3
log10 reduction of 10
3 and 107 CFU mL1 populations of S. au-
reus compared to a slightly increased dose of 41 J cm2 for
equivalent reduction of a 109 CFU mL1 population. The
increase in dose was attributed to attenuation of light passing
through a 109 CFU mL1 population of S. aureus. Light irradi-
ance reduced from 10 mW cm2 at the sample surface to 5.6
mW cm2 after passing through the sample, which was not seen
in samples with a lower population density (7). Additionally,
Bumah et al. (79) demonstrated that bacterial density does not
affect the bactericidal effect of 405 and 470 nm light, but the
reduced light penetration of suspending liquids, due to increased
bacterial concentration, is likely to limit bactericidal effect. It is
also worth noting that the increased doses may also be due to
increased oxygen requirements in larger populations, and as oxy-
gen is necessary for inactivation (6,7), this could be a limiting
factor reducing inactivation efﬁcacy. However, these results are
similar to those of Hessling et al. (88) who also found no
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signiﬁcant correlation between the starting population and dose
requirements.
Trends in Fig. 5 indicate little change in the dose for 1 log10
reduction with increasing irradiance of 405 nm light (with the
exception of L. monocytogenes), with no signiﬁcant correlation
seen. In the case of L. monocytogenes, as the irradiance
increased there was a slight decrease in the dose required. This
opposes results demonstrated by Murdoch et al. (50) who
exposed L. monocytogenes to different irradiances (10, 20, 30
mW cm2) of 405 nm light. Following a dose of 108 J cm2
there was a slight decrease in inactivation from 5.18 log10 to 4.9
log10 reduction when irradiance was increased from 10 to 30
mW cm2. However, as the linear relationship was deemed weak
in Fig. 5, it is still likely that there is an absorption maxima
regardless of the irradiance of light used.
Stronger, signiﬁcant correlation was observed with the rela-
tionship between dose and violet-blue light wavelength. In the
case of S. aureus and P. aeruginosa, there was little change in
dose with increasing wavelength; however, stronger positive cor-
relations were seen for E. coli and L. monocytogenes (Fig. 6).
This indicates that some bacterial strains may be more sensitive
to shorter wavelengths closer to 405 nm rather than those toward
470 nm. 405 nm light was also demonstrated to be the most
effective wavelength for microbial inactivation by Endarko et al.
(52). Exposure of L. monocytogenes to wavelengths between 400
and 450 nm achieved maximum inactivation (1.45 log10 reduc-
tion) following exposure to 405 nm light and least inactivation
(0.04 log10 reduction), using 450 nm light following a dose of
123.3 J cm2 (52).
This ﬁnding was further supported by analysis provided in
Fig. 7. As demonstrated, the majority of the data sets (19/20)
comparing the efﬁcacy of violet-blue wavelengths found that
increased doses were required for bacterial inactivation, or there
was no inactivation achieved when using longer wavelengths
between 450 and 470 nm. This is particularly pertinent in the
case of Edwardsiella tarda with the dose for a 1 log10 reduction
increasing from 68.4 to 544.5 J cm2 when wavelength
increased from 405 to 465 nm (31), Entercoccus faecalis with
the dose increasing from 130 to 410 J cm2 when wavelength
increased from 405 to 455 nm (39), Lactobacillus planterium
with the dose rising from 374 to 1121 J cm2 when wavelength
increased from 405 to 460 nm (58) and L. monocytogenes with
the dose rising from 61.6 to 1120.9 J cm2 when the wavelength
was increased from 405 to 450 nm (52). Studies by Maclean
et al. (12), Lui et al. (39) and Endarko et al. (52) further demon-
strate the superior efﬁcacy of 405 nm light compared to wave-
lengths including 400, 420, 415, 420 and 430 nm for
inactivation of E. faecalis, E. coli, L. monocytogenes and S. au-
reus. Therefore, although the analysis was made on a small
selection of studies (n = 9), the general trend does support the
current thinking that shorter wavelengths in the region of
405 nm are more effective for bacterial inactivation than longer
wavelengths between 450 and 470 nm.
It is also important to note that although the methodology to
calculate dose for 1 log10 reduction was adapted from Hessling
et al. (88), this article has included more papers on bacterial
inactivation by violet-blue light than Hessling et al. (88) (includ-
ing those by Barneck et al. (48), Decarli et al. (60), Fila et al.
(68), Gillespie et al. (74), Gupta et al. (20), Hope et al. (40),
Kawada et al. (67), Kim et al. (51,72), Kotoku et al. (63),
O’Donoghue et al. (59)) and also included inactivation data on
fungi, yeasts, bacteriophage and viruses. Therefore, this review is
a broader representation of the efﬁcacy of violet-blue light
between 380 and 480 nm.
Several other interesting comparisons in respect of tempera-
ture and anaerobic conditions during exposure can be made using
the data from the systematized review (see Supporting Informa-
tion). Decreased or elevated temperatures during violet-blue light
had a varied effect on bacterial inactivation. In the case of
405 nm light exposure in low temperatures (≤10°C), there was
little change in inactivation of Bacillus cereus, Lactobacillus
planetarium and P. aeruginosa (33,58); however, there was
enhanced inactivation of E. coli and L. monocytogenes (43).
Additionally, inactivation of S. aureus was reduced, with approx-
imately 50% less inactivation than that achieved at room temper-
ature (2.1 v 4 log10 reduction) (33,58). When temperature was
increased (≥37°C) during violet-blue light exposure, there was
enhanced inactivation of E. coli, L. monocytogenes and
P. aeruginosa (16,43). This was particularly striking in L. mono-
cytogenes with half the dose required (42 v 84 J cm2) for a 5
log10 reduction following 405 nm light exposure at an irradiance
of 70 mW cm2 (43). McKenzie et al. (43) hypothesized that
the enhanced inactivation seen during exposure in these stressed
conditions may be a result of structural or metabolic stresses
(due to the temperature) which, when combined with 405 nm
light, increased microbial susceptibility to ROS and subsequent
oxidative damage.
As it is known that oxygen plays an essential role in the pho-
toinactivation of microorganisms using violet-blue light (6,7), it
was interesting to compare inactivation of microorganisms
exposed in anaerobic environments, when suspended in phos-
phate-buffered saline or brain–heart infusion broth. Under these
conditions, there was little to no inactivation of bacteria, includ-
ing S. aureus, E. coli and E. faecalis and signiﬁcantly reduced
inactivation (1–5 log10 less) of fungi and yeasts, including Asper-
gillus niger, Candida albicans and Serratia cerevisiae (19,40).
However, up to 4 log10 inactivation of Porphyromonas gingi-
valis, Prevotella intermedia, Prevotella nigrescens and Propioni-
bacterium acnes could be achieved in anaerobic conditions
following violet-blue light exposure (40,62,66). These results fur-
ther demonstrate that environmental pathogens such as S. aureus
require oxygen for violet-blue light inactivation (7); however,
they also indicate that anaerobic oral bacteria such as P. gingi-
valis may not require oxygen for inactivation during violet-blue
light exposure. Hope et al. (40) hypothesized that inactivation of
these oral bacteria may be due to type I reactions occurring
within bacterial cells, producing ion radicals which could cause
damage to cellular structures without requiring oxygen as an
intermediate. This demonstrates that, in certain oxygen depleted
scenarios, violet-blue can still be used for microbial inactivation.
Violet-blue light inactivation of bacteria is thought to occur
through excitation of intracellular porphyrin molecules, resulting
in ROS production, thus promoting oxidative cellular damage
and cell death. This inactivation mechanism has beneﬁts over
other antimicrobial treatments such as antibiotics and ultraviolet
light, in that the generated ROS cause nonspeciﬁc damage (they
do not have speciﬁc cellular target molecules), making organisms
less likely to develop genetic mutations and acquire resistance.
Additionally, the nonspeciﬁc oxidative damage exerted on
exposed microorganisms enables effective inactivation of a wide
range of microbial species. However, very few of the papers
reviewed attempted to investigate the exact mechanism of
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inactivation of violet-blue light. Those which did investigated the
production of ROS and its role in inactivation through the use of
ROS scavengers (6,83), as well as the presence of photosensitive
endogenous porphyrins within microorganism via ﬂuorescence
spectrophotometry or high-performance liquid chromatography
(10,19,23,33,70).
Additional studies have investigated bacterial damage, with
results supporting different hypotheses about the inactivation
mechanism. On the one hand, Enwemeka et al. (76) hypothe-
sized that damage may occur in the double bond between pyrim-
idine bases of DNA, causing new bonds to form between
incorrect base pairs. As the dose delivered would cause the rate
of damage to exceed the rate of repair, cells are likely to die
after exposure to violet-blue light and not photorepair (76). A
recent study by Kim and Yuk (71) supports this hypothesis, with
TEM revealing disorganization of chromosomes and ribosomes
following violet-blue light exposure as well as DNA oxidation.
The authors hypothesized that violet-blue light inactivation was
due to DNA damage and loss of efﬂux pump activity rather than
membrane peroxidation, as no noticeable changes to the cell
envelope were witnessed using microscopy (71).
However, a greater amount of evidence has been produced
which indicates that inactivation is due to membrane damage.
Kim et al. (34,51) exposed B. cereus, E. coli, L. monocytogenes,
Salmonella sonnei, Salmonella typhimurium and S. aureus to
405 nm light and found no DNA damage. There was no evi-
dence of DNA fragmentation or changes in the DNA ladder pro-
ﬁle after performing a comet assay and DNA ladder analysis,
respectively (34,51). Additionally, TEM has been used to
demonstrate structural damage following 415 nm light exposure
of P. aeruginosa and S. aureus. Membrane degradation, large
vacuole formation, release of cytoplasmic material and complete
cell disruption were witnessed in P. aeruginosa, while there was
disruption of cytoplasmic contents, breakage of bacterial cell
walls and cell debris seen in S. aureus samples (69,77). TEM of
C. albicans also revealed decomposition of inner organelles,
deformed cell walls and unusual vacuole growth following a
dose of 35.1 J cm2, and complete loss of cytoplasmic contents
due to disrupted cell walls after a dose of 70.2 J cm2 415 nm
light (23). As there are, as yet, no conclusive answers, and it is
likely that damage will be a result of a combination of factors
due to the nonspeciﬁc oxidative damage that the generated ROS
can induce within the exposed cells, there is a deﬁnite require-
ment for further work to fully establish the inactivation mecha-
nism of action.
For many of the bacterial species (see Supporting Informa-
tion), only one strain has been studied; therefore, it would be
interesting for future research to investigate a wider range of
strains within a bacterial species. Additionally, as antimicrobial
violet-blue light is being developed for a range of clinical appli-
cations, it is important to expand the number of clinical isolates
investigated as there can be large variations in dose require-
ments. This was demonstrated by Halstead et al. (28) who
showed variations in the inactivation of isolates from an English
hospital exposed to 400 nm light. Variation in dose requirements
was particularly notable in clinical isolates of Stenotrophomonas
maltophilia, with between 2.97 and 7.33 log10 reduction
achieved following a dose of 108 J cm2 (28). Very few of the
organisms tested in the 79 studies reviewed have also been mul-
tidrug-resistant (MDR) strains; however, dose requirements do
seem to be similar between antibiotic sensitive and antibiotic-
resistant organisms. For example, an average dose of 7.14 and
7.85 J cm2 was required for 1 log10 reduction of drug-sensitive
and MDR P. aeruginosa (68). As these pathogens are an increas-
ing problem in the hospital environment with very few treatment
options (89), it is very important to continue to establish their
susceptibility to violet-blue light. Successful demonstration of the
reduction of MDR organisms would certainly support the use of
405 nm light for environmental decontamination in hospitals.
It was also apparent when comparing the data collected during
the systematized review that there is a lack of evidence regarding
the antimicrobial effect of violet-blue light on fungi, yeasts, pro-
tozoa and viruses. Only 10 of the studies reviewed investigated
fungi and yeasts with the majority focussing on Gram-positive
and Gram-negative bacteria. Although work has been carried out
on C. albicans, A. niger and Fusobacterium spp, further work is
required to investigate inactivation of additional hospital-acquired
pathogens such as Candida spp. (C. glabrata, C. parapsilosis,
C. tropicalis) Aspergillus spp. (A. fumigates, A. ﬂavus), Muco-
rales, Fusarium spp. (F. moniliforme, F. solani and F. oxyspo-
rum) and Scedosporium spp. (S. apiospermum and S. proliﬁcans)
(90).
Evidence on the potential for violet-blue light inactivation of
other microorganisms such as protozoa and viruses is also lim-
ited. In all the studies reviewed, only one investigated the inacti-
vation of protozoa (namely Acanthamoeba polyphaga, ATCC
30461), with inactivation measured in ﬂuorescence (60). After
doses of 300 J cm2 of 460 nm light, there was a 42% reduction
in ﬂuorescence of a 106 CFU mL1 population compared with
the unexposed control (60). Future work could investigate other
protozoa which are harmful to human health such as Blastocystis
hominis, Cryptosporidium parvum, Entamoeba histolytica and
Giardia lamblia (91). Additionally, results by Tomb et al. (25)
are currently the only published evidence of the virucidal efﬁ-
cacy of 405 nm light against mammalian viruses, demonstrating
that very high doses (~700 J cm2) are required for 1 log10 inac-
tivation when in minimal media (Dulbecco’s phosphate-buffered
saline). Similarly, inactivation of a Streptomyces bacteriophage,
φC31, required high doses of 405 nm light when suspended in
minimal media (1020 J cm2 calculated for a 1 log10 reduction)
(24). It is likely that inactivation requires such high doses due to
the lack of endogenous porphyrins within viral particles, result-
ing in inactivation being due to the low-level UVA output
(~390 nm) emitted from the LEDs, which could cause protein
oxidation (92,93). However, inactivation by 405 nm exposure
can be signiﬁcantly enhanced when viruses are exposed while
suspended in organically rich biologically relevant media, with
88–89% less dose required for 1 log10 reduction of both FCV
and φC31 (24,25). Therefore, additional studies are required to
support these ﬁndings and investigate the most effective wave-
length between 380 and 480 nm which has efﬁcacy against noso-
comial viruses found in bodily ﬂuids in the environment, such as
adenovirus, inﬂuenza virus, norovirus and rotavirus (94–97).
It was clear from the systematized review that there is little
known about the potential for microorganisms to become tolerant
to violet-blue inactivation. Only three of the studies reviewed
investigated the potential for tolerance development in bacteria,
with differing results (30,70,73). Additionally, a study by Zhang
et al. (23) investigated the potential for tolerance in C. albicans
and demonstrated decreased, but not statistically signiﬁcant, sus-
ceptibility to violet-blue light after 10 repeated exposures. It is
therefore particularly important to continue research on the
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potential for tolerance development, to ensure that evidence is
generated from several research groups, using different experi-
mental arrangements, allowing accumulation of data so users can
form unbiased opinions. Investigating tolerance will also help to
ensure that violet-blue light is effectively used within the clinical
environment, and is utilized in a way that in unlikely to result in
resistance and provide reassurance to end point users.
As the systematized review only focussed on laboratory inac-
tivation studies, future reviews could compare the use of violet-
blue light for: wound decontamination (30,70), dental hygiene
(98,99), acne treatments (100,101), prevention of food spoilage
and disinfection of food (102–104) and environmental decontam-
ination purposes (105–108). It is also likely that research papers
will become more transparent in the future as research councils
require data to be deposited in accessible online databases, such
as the UK Data Archive. It may therefore be possible to retrieve
the majority of the raw data from studies and apply mathematical
models to provide more accurate estimates of microbial inactiva-
tion using violet-blue light, which would in turn improve the
value of any systematic reviews published.
Accessible data sets may also include detailed information on
the experimental arrangement, which would allow a more in-depth
analysis on the effect of the set-up between studies. This could
include comparisons between variables such as the light sources,
volume of samples, irradiances and temperatures, which are all
likely to have an impact on the inactivation kinetics. For example,
data on the inactivation of an organism, with known endogenous
photosensitizers, could be compared between studies using a nar-
rowband light source, to that of a monochromatic source, emitting
light at the wavelength associated with peak absorption by the
organism’s porphyrins. This would indicate whether efﬁcacy is
improved using a monochromatic light emitting a single wave-
length, or whether inactivation is similar when a small range of
wavelengths are emitted from the LEDs. Therefore, analysis of
experimental arrangements may highlight important aspects for
future studies, such as the importance of LED selection, and tailor-
ing the wavelength of light to the organisms exposed.
Additionally, to further support the clinical application of violet-
blue light, it would be important to be able to standardize microbial
inactivation studies between differing research groups. One way of
doing so would be to distribute a standardized test panel of organ-
isms, suspended on a 96-well plate, to research groups working
with visible light decontamination technologies. The results could
then be collected into a database and analyzed to ensure that all
groups involved are achieving similar levels of inactivation. There-
fore, outcomes from future studies could be considered more robust
and could be directly compared between groups ensuring greater
transparency and higher impact. Collated results could then be used
when producing standardized procedures for violet-blue light expo-
sure experiments and for clinical treatment applications.
CONCLUSION
This review on the efﬁcacy of antimicrobial 380–480 nm light is
the ﬁrst to encompass the inactivation of a broad range of
microorganisms including Gram-positive and Gram-negative bac-
teria, fungi, yeasts, bacteriophage and viruses. Data gathered
indicated that Gram-negative and Gram-positive vegetative bacte-
ria are the most susceptible organisms, while bacterial endo-
spores, viruses and bacteriophage present the highest dose
requirements for inactivation. This systematized review has
additionally allowed the antimicrobial efﬁcacy of violet-blue light
to be compared when using different irradiances of light, expos-
ing different starting populations and also between the different
wavelengths of light used, as well as highlighting areas of violet-
blue light research which need further work. Analysis indicated
that population density and irradiance of violet-blue light used
are unlikely to have an effect on the average dose requirements
for Gram-positive and Gram-negative bacteria, but this requires
further investigation, with higher populations and peak absorp-
tion maxima potentially inﬂuencing dose requirements of other
organisms not included in the analysis. Interestingly though,
results demonstrated that higher doses are required for inactiva-
tion when longer wavelengths of violet-blue light are used, par-
ticularly in the case of E. coli and L. monocytogenes. This
ﬁnding supports the use of light in the lower region of 405 nm
light for inactivation of microorganisms. However, the review
demonstrated the lack of published data on inactivation of MDR
isolates, fungi, viruses and protozoa, as well as highlighting a
requirement for standardized method for efﬁcacy testing and the
need for further evidence on the mechanism of inactivation and
potential for bacterial tolerance.
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